Companion Animal Vaccines Global Market Report 2026

Description

Companion animal vaccines are biological preparations designed to activate the immune system of pets, enabling them to build protection against particular infectious diseases. They lower the risk, severity, and transmission of illnesses among animals as well as within shared human environments. Companion animal vaccines are essential in preventive veterinary care, as they support animal health, fulfill regulatory requirements, and reduce the risk of zoonotic disease spread.

The primary product types of companion animal vaccines include inactivated, live attenuated, recombinant, and other products. Inactivated refers to vaccines formulated from pathogens that have been killed or rendered non-infectious while maintaining their ability to trigger an immune response in companion animals. The animal framework includes feline, canine, avian, and other animal types and they are administered through oral, parenteral, and other routes of administration. They are categorized by material type such as killed or inactivated vaccines, modified-live vaccines (MLV), recombinant vaccines, and subunit and mRNA-based vaccines and they are distributed through veterinary hospitals, veterinary clinics, pharmacies and drug stores, and other distribution channels.

Tariffs are affecting the companion animal vaccines market by increasing the cost of imported raw materials, biopharmaceutical ingredients, cold-chain logistics equipment, and specialized adjuvants required for vaccine formulation and distribution. This is increasing overall production costs and creating supply chain bottlenecks, particularly in import-dependent regions such as Asia-Pacific and Latin America where veterinary biologics depend on global sourcing. The impact is most significant in advanced recombinant and combination vaccine segments due to their greater reliance on specialized inputs and manufacturing technologies. However, tariffs are also encouraging domestic vaccine production, regional biomanufacturing investments, and supplier diversification, which are enhancing long-term resilience and self-sufficiency within veterinary healthcare ecosystems.

The companion animal vaccines market research report is one of a series of new reports from The Business Research Company that provides companion animal vaccines market statistics, including companion animal vaccines industry global market size, regional shares, competitors with a companion animal vaccines market share, detailed companion animal vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal vaccines industry. This companion animal vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal vaccines market size has grown rapidly in recent years. It will grow from $4.55 billion in 2025 to $5.01 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising prevalence of infectious diseases in companion animals, growth in pet ownership globally, expansion of veterinary clinic networks, increased awareness of preventive pet healthcare, introduction of core vaccination programs for pets.

The companion animal vaccines market size is expected to see rapid growth in the next few years. It will grow to $7.41 billion by 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for personalized pet healthcare solutions, growth in pet insurance coverage driving vaccination uptake, rising investment in advanced recombinant and mRNA vaccine platforms, expansion of emerging market veterinary infrastructure, growing focus on zoonotic disease prevention and global health security. Major trends in the forecast period include increasing pet humanization driving higher vaccination compliance and preventive healthcare adoption, rising awareness of zoonotic disease transmission boosting routine immunization in companion animals, expansion of veterinary healthcare infrastructure and clinic networks improving vaccine accessibility, growing use of combination and multivalent vaccines to reduce multiple injections and improve compliance, strengthening regulatory mandates and pet travel requirements enforcing vaccination standards.

The increasing spending on pet healthcare is expected to propel the growth of the companion animal vaccines market going forward. Pet healthcare spending refers to the total financial outlay by pet owners on veterinary services, preventive care, medications, and related health products for their companion animals. The increasing spending on pet healthcare due to the rising trend of pet humanization, where owners treat pets as family members, is a key contributing factor driving market expansion, as it encourages greater investment in preventive and routine veterinary care, including vaccinations, to support long-term animal well-being. The rising expenditure on pet healthcare is supporting and propelling the demand for companion animal vaccines, as pet owners increasingly seek preventive solutions to protect their animals from infectious and life-threatening diseases. For instance, in March 2024, according to the American Pet Products Association (APPA), a US-based trade association for the pet industry, veterinary care and product sales in the United States rose from $35.9 billion in 2022 to $38.3 billion in 2023, reflecting an increase of $2.4 billion. Therefore, increasing spending on pet healthcare is driving and supporting the growth of the companion animal vaccines market.

Leading companies operating in the companion animal vaccines market are focusing on developing innovative products such as injectable recombinant vaccines to enhance immunization effectiveness and improve administration flexibility. An injectable recombinant vaccine is a biologically engineered immunization that uses recombinant antigens to induce a targeted immune response in animals. For example, in November 2025, Zoetis Services LLC, a US-based animal health company, launched Vanguard Recombishield. It is a non-adjuvanted, recombinant injectable vaccine that incorporates the pertactin protein to enable more precise immune system targeting while reducing adverse reactions during administration. It also offers a more comfortable and versatile vaccination approach, supporting improved compliance and effective prevention of respiratory infections in dogs.

In June 2023, Mars Inc., a US-based manufacturing company, acquired Heska Corp. for an amount of $1.3 billion. This acquisition strengthens Mars Petcare's veterinary care capabilities and advances its commitment to improving pet health. Heska is now part of Mars Petcare's science and diagnostics division, including Antech Diagnostics. The integration enhances diagnostic services for veterinary professionals and pet owners, expanding access to advanced diagnostic technologies and accelerating research and development in veterinary healthcare. Heska Corp is a US-based veterinary services company specializing in developing, manufacturing, and commercializing advanced veterinary diagnostic and related vaccines for canine and feline health.

Major companies operating in the companion animal vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Ceva Sante Animale S. A., Virbac S. A., Phibro Animal Health Corporation, Neogen Corporation, Vetoquinol S. A., Norbrook Laboratories Limited, HIPRA S. A., Indian Immunologicals Limited, Vaxxinova International B. V., Bimeda Animal Health Limited, Laboratorios Calier S. A., Hester Biosciences Limited, ChoongAng Vaccine Laboratories Co. Ltd., Elanco Animal Health Incorporated, Bioveta a. s., CZ Veterinaria S. A., Intervet Inc. (Merck Animal Health), Brilliant Bio Pharma Private Limited, Durvet Inc., Kyoritsu Seiyaku Corporation

North America was the largest region in the companion animal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the companion animal vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the companion animal vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The companion animal vaccines market consists of sales of subunit vaccines, DNA vaccines, rabies vaccines, and distemper vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses companion animal vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The companion animal vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Inactivated; Live Attenuated; Other Products
2) By Animal Type: Feline; Canine; Avian; Other Animal Types
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Material Type: Killed Or Inactivated Vaccines; Modified-Live Vaccines (MLV); Recombinant Vaccines; Subunit And mRNA-Based Vaccines
5) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores; Other Distribution Channels
Subsegments:
1) By Inactivated: Killed Viral Vaccine; Killed Bacterial Vaccine; Toxoid Vaccine; Subunit Vaccine
2) By Live Attenuated: Modified Live Viral Vaccine; Modified Live Bacterial Vaccine; Chimeric Vaccine; Attenuated Parasite Vaccine
3) By Other Products: Combination Vaccine; Adjuvanted Vaccine; Autogenous Vaccine; Novel Platform Vaccine
Companies Mentioned: Boehringer Ingelheim International GmbH; Zoetis Inc.; Ceva Sante Animale S.A.; Virbac S.A.; Phibro Animal Health Corporation; Neogen Corporation; Vetoquinol S.A.; Norbrook Laboratories Limited; HIPRA S.A.; Indian Immunologicals Limited; Vaxxinova International B.V.; Bimeda Animal Health Limited; Laboratorios Calier S.A.; Hester Biosciences Limited; ChoongAng Vaccine Laboratories Co. Ltd.; Elanco Animal Health Incorporated; Bioveta a.s.; CZ Veterinaria S.A.; Intervet Inc. (Merck Animal Health); Brilliant Bio Pharma Private Limited; Durvet Inc.; Kyoritsu Seiyaku Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: VH5MCAVN01_G26Q2

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Companion Animal Vaccines Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Companion Animal Vaccines Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Companion Animal Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Companion Animal Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Increasing Pet Humanization Driving Higher Vaccination Compliance And Preventive Healthcare Adoption
- 4.2.2 Rising Awareness Of Zoonotic Disease Transmission Boosting Routine Immunization In Companion Animals
- 4.2.3 Expansion Of Veterinary Healthcare Infrastructure And Clinic Networks Improving Vaccine Accessibility
- 4.2.4 Growing Use Of Combination And Multivalent Vaccines To Reduce Multiple Injections And Improve Compliance
- 4.2.5 Strengthening Regulatory Mandates And Pet Travel Requirements Enforcing Vaccination Standards

5. Companion Animal Vaccines Market Analysis Of End Use Industries

5.1 Veterinary Hospitals
5.2 Veterinary Clinics
5.3 Pet Owners
5.4 Animal Shelters
5.5 Breeders And Kennels

6. Companion Animal Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Companion Animal Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Companion Animal Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Companion Animal Vaccines Market Size, Comparisons And Growth Rate Analysis
7.3. Global Companion Animal Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Companion Animal Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Companion Animal Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Companion Animal Vaccines Market Segmentation

9.1. Global Companion Animal Vaccines Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inactivated, Live Attenuated, Other Products
9.2. Global Companion Animal Vaccines Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Feline, Canine, Avian, Other Animal Types
9.3. Global Companion Animal Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Parenteral, Other Routes Of Administration
9.4. Global Companion Animal Vaccines Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Killed Or Inactivated Vaccines, Modified-Live Vaccines (MLV), Recombinant Vaccines, Subunit And mRNA-Based Vaccines
9.5. Global Companion Animal Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels
9.6. Global Companion Animal Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Killed Viral Vaccine, Killed Bacterial Vaccine, Toxoid Vaccine, Subunit Vaccine
9.7. Global Companion Animal Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Modified Live Viral Vaccine, Modified Live Bacterial Vaccine, Chimeric Vaccine, Attenuated Parasite Vaccine
9.8. Global Companion Animal Vaccines Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Combination Vaccine, Adjuvanted Vaccine, Autogenous Vaccine, Novel Platform Vaccine

10. Companion Animal Vaccines Market Regional And Country Analysis

10.1. Global Companion Animal Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Companion Animal Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Companion Animal Vaccines Market

11.1. Asia-Pacific Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Companion Animal Vaccines Market

12.1. China Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Companion Animal Vaccines Market

13.1. India Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Companion Animal Vaccines Market

14.1. Japan Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Companion Animal Vaccines Market

15.1. Australia Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Companion Animal Vaccines Market

16.1. Indonesia Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Companion Animal Vaccines Market

17.1. South Korea Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Companion Animal Vaccines Market

18.1. Taiwan Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Companion Animal Vaccines Market

19.1. South East Asia Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Companion Animal Vaccines Market

20.1. Western Europe Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Companion Animal Vaccines Market

21.1. UK Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Companion Animal Vaccines Market

22.1. Germany Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Companion Animal Vaccines Market

23.1. France Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Companion Animal Vaccines Market

24.1. Italy Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Companion Animal Vaccines Market

25.1. Spain Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Companion Animal Vaccines Market

26.1. Eastern Europe Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Companion Animal Vaccines Market

27.1. Russia Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Companion Animal Vaccines Market

28.1. North America Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Companion Animal Vaccines Market

29.1. USA Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Companion Animal Vaccines Market

30.1. Canada Companion Animal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Companion Animal Vaccines Market

31.1. South America Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Companion Animal Vaccines Market

32.1. Brazil Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Companion Animal Vaccines Market

33.1. Middle East Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Companion Animal Vaccines Market

34.1. Africa Companion Animal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Companion Animal Vaccines Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Companion Animal Vaccines Market Regulatory and Investment Landscape

36. Companion Animal Vaccines Market Competitive Landscape And Company Profiles

36.1. Companion Animal Vaccines Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Companion Animal Vaccines Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Companion Animal Vaccines Market Company Profiles
- 36.3.1. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Ceva Sante Animale S.A. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Virbac S.A. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Phibro Animal Health Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Companion Animal Vaccines Market Other Major And Innovative Companies

Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, HIPRA S.A., Indian Immunologicals Limited, Vaxxinova International B.V., Bimeda Animal Health Limited, Laboratorios Calier S.A., Hester Biosciences Limited, ChoongAng Vaccine Laboratories Co. Ltd., Elanco Animal Health Incorporated, Bioveta a.s., CZ Veterinaria S.A., Intervet Inc. (Merck Animal Health), Brilliant Bio Pharma Private Limited

38. Global Companion Animal Vaccines Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Companion Animal Vaccines Market

41. Companion Animal Vaccines Market High Potential Countries, Segments and Strategies

41.1 Companion Animal Vaccines Market In 2030 - Countries Offering Most New Opportunities
41.2 Companion Animal Vaccines Market In 2030 - Segments Offering Most New Opportunities
41.3 Companion Animal Vaccines Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer